BioCardia, Inc. (BCDA) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2009: $4.97M2010: $127.0K2011: $12.68M2012: $13.27M2013: $13.29M2014: $3.18M2015: $3.56M2016: $21.35M2017: $12.69M2018: $5.36M2019: $5.58M2020: $21.41M2021: $12.87M2022: $7.36M2023: $1.10M2024: $2.37M2025: $2.50M$2.50M
2009Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$2.50M+5.3%
2024$2.37M+115.0%
2023$1.10M-85.0%
2022$7.36M-42.8%
2021$12.87M-39.9%
2020$21.41M+283.3%
2019$5.58M+4.2%
2018$5.36M-57.8%
2017$12.69M-40.6%
2016$21.35M+500.3%
2015$3.56M+11.7%
2014$3.18M-76.1%
2013$13.29M+0.2%
2012$13.27M+4.7%
2011$12.68M+9882.7%
2010$127.0K-97.4%
2009$4.97M